In heterogeneous catalysis, catalysts provide a surface to which reactants bind in a process of adsorption. Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction. 103260-44-2, Name is Ethyl 2-(tetrahydro-2H-pyran-4-yl)acetate, molecular formula is C9H16O3. In a Patent，once mentioned of 103260-44-2, Safety of Ethyl 2-(tetrahydro-2H-pyran-4-yl)acetate
Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson”s Disease, Tourette”s Syndrome, attention deficient disorder, or schizophrenia), are treated by administering a 1-aza-2-(3-pyridyl)bicyclo[2.2.1]heptane, a 1-aza-2-(3-pyridyl)bicyclo[2.2.2]octane, a 1-aza-2-(3-pyridyl)bicyclo[3.2.1]octane, a 1-aza-2-(3-pyridyl)bicyclo[3.2.2]nonane, a 1-aza-7-(3-pyridyl) bicyclo[2.2.1]heptane, a 1-aza-3-(3-pyridyl)bicyclo[3.2.2]nonane, or a 1-aza-7-(3-pyridyl)bicyclo[3.2.2]nonane. The compounds can exist as individual stereoisomers, racemic mixtures, diastereomers and the like.
Safety of Ethyl 2-(tetrahydro-2H-pyran-4-yl)acetate, In the meantime we’ve collected together some recent articles in this area about Safety of Ethyl 2-(tetrahydro-2H-pyran-4-yl)acetate to whet your appetite. Happy reading!
Reference：
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics